IDO1 and cancer: It is well documented from studies in mouse models and patients that IDO expressed in cancer cells or DC in the cancer microenvironment mediates immunosuppressive effects and tolerance to tumor via mechanisms independent from l-tryptophan deprivation [177, 178].